Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-11-21

Clinical Trial Update: Study to Evaluate the Effects of Colesevelam on Insulin Sensitivity and ß-Cell Function in Subjects With Impaired Fasting Glucose (Prediabetes) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Colesevelam for insulin sensitivity and beta-cell function in adults with impaired fasting glucose (prediabetes) has completed, with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Welchol (colesevelam hydrochloride)

Snippet

Sponsor: Seattle Institute for Biomedical and Clinical Research | Conditions: Impaired Fasting Glucose, Prediabetes | Phase 3 | Status: COMPLETED | Results posted: 2012-11-21